{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:06:14Z","timestamp":1788951974253,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clbc.2026.07.014","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:34:07Z","timestamp":1784244847000},"page":"14-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unraveling Time-Varying Effects of Risk Factors for Contralateral Invasive Breast Cancer Following Ductal Carcinoma In Situ"],"prefix":"10.1016","volume":"26","author":[{"given":"Yixin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1266-8943","authenticated-orcid":false,"given":"Jiuda","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2026.07.014_bib0001","first-page":"4","article-title":"Mammography screening and incidence of ductal carcinoma in situ of the breast in Italy: an age-period-cohort analysis","volume":"115","author":"Bucchi","year":"2025","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0002","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13058-023-01682-9","article-title":"Non-progressive breast carcinomas detected at mammography screening: a population study","volume":"25","author":"Heggland","year":"2023","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2026.07.014_bib0003","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence","volume":"367","author":"Bleyer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2026.07.014_bib0004","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0011-3840(05)80019-X","article-title":"Ductal carcinoma in situ of the breast: progress and controversy","volume":"33","author":"Swallow","year":"1996","journal-title":"Curr Probl Surg"},{"key":"10.1016\/j.clbc.2026.07.014_bib0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2026.07.014_bib0006","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djp482","article-title":"Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes","volume":"102","author":"Virnig","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2026.07.014_bib0007","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/S0140-6736(24)00425-2","article-title":"Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment","volume":"403","author":"Delaloge","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2026.07.014_bib0008","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.soc.2023.05.011","article-title":"How to navigate the treatment spectrum from multimodality therapy to observation alone for ductal carcinoma in situ","volume":"32","author":"Record","year":"2023","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.clbc.2026.07.014_bib0009","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-med-050715-104920","article-title":"Controversies in the treatment of ductal carcinoma in situ","volume":"68","author":"Barrio","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.clbc.2026.07.014_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5344","article-title":"Treatment of ductal carcinoma in situ","volume":"343","author":"Smith","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2026.07.014_bib0011","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.clbc.2026.07.014_bib0012","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - the LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2026.07.014_bib0013","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2026.07.014_bib0014","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1245\/s10434-019-07628-w","article-title":"Trends in unilateral and contralateral prophylactic mastectomy use in ductal carcinoma In situ of the breast: patterns and predictors","volume":"26","author":"Zhang","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamasurg.2014.2895","article-title":"Nationwide trends in mastectomy for early-stage breast cancer","volume":"150","author":"Kummerow","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.clbc.2026.07.014_bib0016","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaoncol.2024.2212","article-title":"Bilateral mastectomy and breast cancer mortality","volume":"10","author":"Giannakeas","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0017","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamasurg.2020.0322","article-title":"Deimplementation of the choosing wisely recommendations for low-value breast cancer surgery: a systematic review","volume":"155","author":"Wang","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.clbc.2026.07.014_bib0018","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1245\/s10434-017-5931-2","article-title":"Contralateral breast cancer risk in women with ductal carcinoma in situ: is it high enough to justify bilateral mastectomy?","volume":"24","author":"Miller","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0019","article-title":"Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study","volume":"369","author":"Mannu","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2026.07.014_bib0020","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/SLA.0000000000002239","article-title":"Cause-specific mortality in a population-based cohort of 9799 women treated for ductal carcinoma In situ","volume":"267","author":"Elshof","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2026.07.014_bib0021","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41416-021-01417-7","article-title":"The risk of contralateral breast cancer: a SEER-based analysis","volume":"125","author":"Giannakeas","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2026.07.014_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103764","article-title":"DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS","volume":"77","author":"Engelhardt","year":"2024","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2026.07.014_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113276","article-title":"Active surveillance versus treatment in low-risk DCIS: women's preferences in the LORD-trial","volume":"192","author":"Schmitz","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2026.07.014_bib0024","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.28977","article-title":"Racial and ethnic disparities in rates of invasive second breast cancer among women with ductal carcinoma In situ in Hawai'i","volume":"4","author":"Taparra","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clbc.2026.07.014_bib0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41523-020-00202-8","article-title":"Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer","volume":"6","author":"Giardiello","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.clbc.2026.07.014_bib0026","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10549-016-3973-y","article-title":"Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women","volume":"159","author":"Elshof","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2026.07.014_bib0027","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0960-9776(03)00152-8","article-title":"The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry","volume":"12","author":"Claus","year":"2003","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2026.07.014_bib0028","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1200\/JCO.2007.14.1192","article-title":"Survival end point reporting in randomized cancer clinical trials: a review of major journals","volume":"26","author":"Mathoulin-Pelissier","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0029","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/aje\/kwq481","article-title":"Bias due to left truncation and left censoring in longitudinal studies of developmental and disease processes","volume":"173","author":"Cain","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.21037\/atm.2018.02.12","article-title":"Time-varying covariates and coefficients in Cox regression models","volume":"6","author":"Zhang","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.clbc.2026.07.014_bib0031","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2288-10-20","article-title":"Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer","volume":"10","author":"Bellera","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0032","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/jrsm.1722","article-title":"Bayesian pairwise meta-analysis of time-to-event outcomes in the presence of non-proportional hazards: a simulation study of flexible parametric, piecewise exponential and fractional polynomial models","volume":"15","author":"Freeman","year":"2024","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.clbc.2026.07.014_bib0033","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/sim.9259","article-title":"Using fractional polynomials and restricted cubic splines to model non-proportional hazards or time-varying covariate effects in the Cox regression model","volume":"41","author":"Austin","year":"2022","journal-title":"Stat Med"},{"key":"10.1016\/j.clbc.2026.07.014_bib0034","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.breast.2017.10.008","article-title":"Metastasis-free interval in breast cancer patients: thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience","volume":"37","author":"Houz\u00e9 de l'Aulnoit","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2026.07.014_bib0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.recesp.2011.01.019","article-title":"Regression modeling strategies","volume":"64","author":"N\u00fa\u00f1ez","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0036","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1037\/a0027127","article-title":"Model selection and psychological theory: a discussion of the differences between the Akaike information criterion (AIC) and the Bayesian information criterion (BIC)","volume":"17","author":"Vrieze","year":"2012","journal-title":"Psychol Methods"},{"key":"10.1016\/j.clbc.2026.07.014_bib0037","series-title":"Applied Logistic Regression","author":"Hosmer","year":"2013"},{"key":"10.1016\/j.clbc.2026.07.014_bib0038","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028063","article-title":"Five-year hospital readmission after coronary artery bypass surgery and the association with off-pump surgery and sex","volume":"12","author":"Dimagli","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.clbc.2026.07.014_bib0039","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0735-1097(98)00563-4","article-title":"CASS Registry long term surgical survival. Coronary artery surgery study","volume":"33","author":"Myers","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10549-024-07599-x","article-title":"Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort study","volume":"210","author":"Rohan","year":"2025","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2026.07.014_bib0041","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/BCTT.S346301","article-title":"Micropapillary breast carcinoma: from molecular pathogenesis to prognosis","volume":"14","author":"Verras","year":"2023","journal-title":"Breast Canc Target Ther"},{"key":"10.1016\/j.clbc.2026.07.014_bib0042","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.2009.169","article-title":"Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study","volume":"23","author":"Castellano","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0043","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12916-022-02260-0","article-title":"The impact of race and ethnicity in breast cancer-disparities and implications for precision oncology","volume":"20","author":"Hirko","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.clbc.2026.07.014_bib0044","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/gim.2017.96","article-title":"Racial\/ethnic differences in multiple-gene sequencing results for hereditary cancer risk","volume":"20","author":"Caswell-Jin","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.clbc.2026.07.014_bib0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clinimag.2021.11.018","article-title":"Contralateral breast cancer after curative-intent treatment for ductal carcinoma in situ: rate and associated clinicopathological and imaging risk factors","volume":"82","author":"Hovis","year":"2022","journal-title":"Clin Imaging"},{"key":"10.1016\/j.clbc.2026.07.014_bib0046","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0047","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.breast.2005.02.002","article-title":"Histopathological and cell biological characteristics of ductal carcinoma in situ (DCIS) of the breast-a comparison between the primary DCIS and subsequent ipsilateral and contralateral tumours","volume":"14","author":"Idvall","year":"2005","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2026.07.014_bib0048","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3390\/cancers17040613","article-title":"BRCA1 and BRCA2 mutations in Polish women with ductal carcinoma In situ","volume":"11","author":"Feszak","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2026.07.014_bib0049","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1078-0432.CCR-24-1884","article-title":"Pathogenic variants in cancer susceptibility genes predispose to ductal carcinoma In situ of the breast","volume":"31","author":"Huang","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2026.07.014_bib0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.52158","article-title":"Breast cancer susceptibility gene sequence variations and development of contralateral Breast cancer","volume":"7","author":"Reiner","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clbc.2026.07.014_bib0051","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1200\/JCO.22.01239","article-title":"Contralateral breast cancer risk among carriers of germline pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2","volume":"41","author":"Yadav","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0052","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.2015.62.3942","article-title":"Impact of age at primary breast cancer on contralateral breast cancer risk in BRCA1\/2 mutation carriers","volume":"34","author":"van den Broek","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0053","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1200\/JCO.2011.36.4976","article-title":"Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision","volume":"30","author":"Yi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2026.07.014_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104521","article-title":"Tin Tin S. The effects of adjuvant endocrine therapy on long-term outcomes from ductal carcinoma in situ: a systematic review and meta-analysis","volume":"82","author":"Chen","year":"2025","journal-title":"Breast"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:07:33Z","timestamp":1788948453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926001151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1526820926001151"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.07.014","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling Time-Varying Effects of Risk Factors for Contralateral Invasive Breast Cancer Following Ductal Carcinoma In Situ","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}